BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $838,000 | -31.1% | 5,544 | -33.6% | 0.00% | – |
| Q2 2022 | $1,216,000 | -87.2% | 8,349 | -89.5% | 0.00% | -100.0% |
| Q1 2022 | $9,469,000 | -32.3% | 79,872 | -21.3% | 0.00% | -33.3% |
| Q4 2021 | $13,988,000 | -94.3% | 101,508 | -94.3% | 0.00% | -94.4% |
| Q3 2021 | $246,902,000 | +77.7% | 1,777,418 | +24.2% | 0.05% | +80.0% |
| Q2 2021 | $138,939,000 | +79.1% | 1,431,187 | +26.1% | 0.03% | +76.5% |
| Q1 2021 | $77,592,000 | -9.3% | 1,135,210 | +13.7% | 0.02% | -19.0% |
| Q4 2020 | $85,542,000 | +23.5% | 998,037 | -6.3% | 0.02% | +10.5% |
| Q3 2020 | $69,244,000 | +6.9% | 1,065,123 | +20.2% | 0.02% | 0.0% |
| Q2 2020 | $64,762,000 | +460.1% | 885,817 | +160.7% | 0.02% | +375.0% |
| Q1 2020 | $11,563,000 | +533.9% | 339,786 | +914.3% | 0.00% | – |
| Q4 2019 | $1,824,000 | +11.6% | 33,501 | -14.5% | 0.00% | – |
| Q3 2019 | $1,634,000 | +12.5% | 39,170 | +18.1% | 0.00% | – |
| Q2 2019 | $1,453,000 | -21.9% | 33,175 | -8.3% | 0.00% | -100.0% |
| Q1 2019 | $1,861,000 | +25.8% | 36,165 | -9.5% | 0.00% | – |
| Q4 2018 | $1,479,000 | +2.3% | 39,974 | +3.7% | 0.00% | – |
| Q3 2018 | $1,446,000 | -3.0% | 38,535 | +2.1% | 0.00% | – |
| Q2 2018 | $1,491,000 | +40.7% | 37,728 | -8.4% | 0.00% | – |
| Q1 2018 | $1,060,000 | +31.7% | 41,184 | +38.2% | 0.00% | – |
| Q4 2017 | $805,000 | -39.9% | 29,811 | -16.7% | 0.00% | – |
| Q3 2017 | $1,339,000 | +104.4% | 35,807 | +36.6% | 0.00% | – |
| Q2 2017 | $655,000 | – | 26,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |